{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:34:27Z","timestamp":1791200067613,"version":"4.2.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1998,12,1]],"date-time":"1998-12-01T00:00:00Z","timestamp":912470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Drug Metab. Pharmacokinet."],"published-print":{"date-parts":[[1998,12]]},"DOI":"10.1007\/bf03189993","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T01:33:16Z","timestamp":1280885596000},"page":"443-451","source":"Crossref","is-referenced-by-count":71,"title":["Drug-induced immunotoxicity"],"prefix":"10.1007","volume":"23","author":[{"given":"P. M.","family":"Dansette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bonierbale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Minoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. H.","family":"Beaune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Pessayre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Mansuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"8504","key":"BF03189993_CR1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0140-6736(86)92144-6","volume":"2","author":"S. Sherlock","year":"1986","unstructured":"Sherlock S. (1986): The spectrum of hepatotoxicity due to drugs. Lancet, 2: 8504, 440\u2013441.","journal-title":"Lancet"},{"key":"BF03189993_CR2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-3565(25)29666-5","volume":"187","author":"J.R. Mitchell","year":"1973","unstructured":"Mitchell J.R., Jollow D.J., Potter W.Z., Gilette J.R., Brodie B.B. (1973): Acetaminophen- induced hepatic necrosis IV. J. Pharmacol. Exp. Ther., 187, 211\u2013217.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF03189993_CR3","volume-title":"Drug-induced hepatic injury","author":"B.H.C. Stricker","year":"1992","unstructured":"Stricker B.H.C. (1992): Drug-induced hepatic injury. Stricker, B.H.C., (Ed.). Elsevier, Amsterdam."},{"issue":"7911","key":"BF03189993_CR4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(75)93001-9","volume":"1","author":"J. Trowell","year":"1975","unstructured":"Trowell J., Peto R., Crampton J., Smith A. (1975): Controlled trial of repeated halothane anaesthetics in patients with carcinoma of the uterine cervix treated with radium. Lancet, 1: 7911, 821\u2013824.","journal-title":"Lancet"},{"issue":"7911","key":"BF03189993_CR5","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(75)93000-7","volume":"1","author":"R. Wright","year":"1975","unstructured":"Wright R., Eade O.E., Chisolm M., Hawksley M., Lloyd B., Moles T.M., Edwards J.C., Gardner M.J. (1975): Controlled prospective study of the effect on liver function of multiple exposures to halothane. Lancet, 1: 7911, 817\u2013820.","journal-title":"Lancet"},{"key":"BF03189993_CR6","volume-title":"Hepatotoxicity. The Adverse Effects of Drugs and other Chemicals on the Liver","author":"H.J. Zimmerman","year":"1978","unstructured":"Zimmerman H.J. (1978): Hepatotoxicity. The Adverse Effects of Drugs and other Chemicals on the Liver. Appleton Century Crofts, New York."},{"key":"BF03189993_CR7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1054-3589(08)60175-1","volume":"30","author":"P.H. Beaune","year":"1994","unstructured":"Beaune P.H., Pessayre D., Dansette P.M., Mansuy D., Manns M. (1994): Autoantibodies against cytochrome P450: role in human diseases. Adv. Pharmacol. 30, 199\u2013245.","journal-title":"Adv. Pharmacol."},{"key":"BF03189993_CR8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-3-642-61013-4_6","volume-title":"Drug-Induced Hepatotoxicity","author":"J. S. Leeder","year":"1996","unstructured":"Leeder J. S., Okey A. B. (1996): Cytochromes P450 and liver injury. In Cameron R. G., Feuer G., Delaiglesia F. A. (Eds.). Drug-Induced Hepatotoxicity, Berlin, Springer-Verlag, 119\u2013153."},{"key":"BF03189993_CR9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0022-3565(25)32240-8","volume":"214","author":"I.G. Sipes","year":"1980","unstructured":"Sipes I.G., Gandolfi J., Pohl L.R., Krishna G., Brown B.R. (1980): Comparison of the biotransformation and hepatotoxicity of halothane and deuterated halothane. J. Pharmacol. Exp. Ther., 214, 716\u2013720.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF03189993_CR10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00000542-198209000-00003","volume":"57","author":"J.L. Plummer","year":"1982","unstructured":"Plummer J.L., Beckwith A.L.J., Bastin F.N., Adams J.F., Cousins M., Hall P. (1982): Free radical formation in vivo and hepatotoxicity due to anesthesia with halothane. Anesthesiology, 57, 160\u2013166.","journal-title":"Anesthesiology"},{"key":"BF03189993_CR11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0022-3565(25)22885-3","volume":"233","author":"H. Satoh","year":"1985","unstructured":"Satoh H., Fukuda Y., Anderson D.K., Ferrans V.J., Gillette J.R., Pohl L.R. (1985): Immunological studies on the mechanism of halothane-induced hepatotoxicity: immunohistochemical evidence of trifluoroacetylated hepatocytes. J. Pharmacol. Exp. Ther., 233, 857\u2013862.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF03189993_CR12","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0090-9556(25)08653-2","volume":"18","author":"J.G. Kenna","year":"1990","unstructured":"Kenna J.G., Martin J.L., Satoh H., Pohl L.R. (1990): Factors affecting the expression of trifluoroacetylated liver microsomal protein neoantigens in rats treated with halothane. Drug Metab. Dispos., 18, 788\u2013793.","journal-title":"Drug Metab. Dispos."},{"key":"BF03189993_CR13","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0026-895X(25)14180-1","volume":"28","author":"H. Satoh","year":"1985","unstructured":"Satoh H., Gillette J.R., Davies H.W., Schulick R.D., Pohl L.R. (1985): Immunochemical evidence of trifluoroacetylated cytochrome P450 in the liver of halothane-treated rats. Mol. Pharmacol., 28, 468\u2013474.","journal-title":"Mol. Pharmacol."},{"key":"BF03189993_CR14","first-page":"187","volume":"10","author":"H. Satoh","year":"1987","unstructured":"Satoh H., Davies H.W., Takemura T., Gillette J.R., Maeda K., Pohl L.R. (1987): An immunochemical approach to investigating the mechanism of halothane-induced hepatotoxicity. Progr. Drug Metab., 10, 187\u2013205.","journal-title":"Progr. Drug Metab."},{"key":"BF03189993_CR15","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.86.1.322","volume":"86","author":"H. Satoh","year":"1989","unstructured":"Satoh H., Martin B.M., Schulick A.H., Christ D.D., Kenna J.G., Pohl L.R. (1989): Human anti- endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase. Proc. Natl. Acad. Sci.U.S.A., 86, 322\u2013326.","journal-title":"Proc. Natl. Acad. Sci.U.S.A."},{"key":"BF03189993_CR16","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/0014-2999(90)94225-M","volume":"183","author":"J.G. Kenna","year":"1990","unstructured":"Kenna J.G., Martin J.L., Pohl L.R. (1990): Purification of trifluoroacetylated protein antigens from livers of halothane-treated rats. Eur. J. Pharmacol., 183, 1139\u20131140.","journal-title":"Eur. J. Pharmacol."},{"key":"BF03189993_CR17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0006-2952(92)90395-Y","volume":"44","author":"J.G. Kenna","year":"1992","unstructured":"Kenna J.G., Martin J.L., Pohl L.R. (1992): The topography of trifluoroacetylated protein antigens in liver microsomal fractions from halothane-treated rats. Biochem. Pharmacol., 44, 621\u2013629.","journal-title":"Biochem. Pharmacol."},{"key":"BF03189993_CR18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0026-895X(25)09316-2","volume":"50","author":"E. Eliasson","year":"1996","unstructured":"Eliasson E., Kenna J.G. (1996): Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis. Mol. Pharmacol., 50, 573\u2013582.","journal-title":"Mol. Pharmacol."},{"key":"BF03189993_CR19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1432-1033.1992.tb17456.x","volume":"210","author":"J. Gut","year":"1992","unstructured":"Gut J., Christen U., Huwyler J., Burgin M., Kenna J.G. (1992): Molecular mimicry of trifluoroacetylated human liver protein adducts by constitutive proteins and immunochemical evidence for its impairment in halothane hepatitis. Eur. J. Biochem., 210, 569\u2013576.","journal-title":"Eur. J. Biochem."},{"key":"BF03189993_CR20","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/bi00057a013","volume":"32","author":"U. Christen","year":"1993","unstructured":"Christen U., Jeno P., Gut J. (1993): Halothane metabolism: the dihydrolipoamide acetyltransferase subunit of the pyruvate dehydrogenase complex molecularly mimics trifluoroacetyl-protein adducts. Biochemistry, 32, 1492\u20131499.","journal-title":"Biochemistry"},{"key":"BF03189993_CR21","first-page":"154","volume":"34","author":"J.G. Kenna","year":"1992","unstructured":"Kenna J.G., Scatchard K., Van Pelt F.N.A.M., Knight T.L. (1992): Antibodies to halothane- induced liver antigens in sera from patients with halothane hepatitis: evidence for conformation-dependent antigen. Br. J. Clin. Pharmacol., 34, 154.","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BF03189993_CR22","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1021\/tx960083q","volume":"9","author":"M. Bourdi","year":"1996","unstructured":"Bourdi M., Chen W.Q., Peter R.M., Martin J.L., Buters J.T.M., Nelson S.D., Pohl L.R. (1996): Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis. Chem. Res. Toxicol., 9, 1159\u20131166.","journal-title":"Chem. Res. Toxicol."},{"key":"BF03189993_CR23","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0022-3565(24)36603-0","volume":"281","author":"D.K. Spracklin","year":"1997","unstructured":"Spracklin D.K., Hankins D.C., Fisher J.M. Thummel K.E., Kharasch E. D. (1997): Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro. J. Pharmacol. Exp. Ther., 281, 400\u2013411.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF03189993_CR24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000237642","volume":"114","author":"S.M. Furst","year":"1997","unstructured":"Furst S.M., Gandolfi A.J. (1997): Interaction of lymphocytes with Kupffer cells from halothane- exposed guinea pigs. Int. Arch. Allergy Immunol., 114, 46\u201353.","journal-title":"Int. Arch. Allergy Immunol."},{"key":"BF03189993_CR25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0300-483X(97)03649-4","volume":"120","author":"S.M. Furst","year":"1997","unstructured":"Furst S.M., Luedke D., Gandolfi A.J. (1997): Kupffer cells from halothane-exposed guinea pigs carry trifluoroacetylated protein adducts. Toxicology, 120, 119\u2013132.","journal-title":"Toxicology"},{"key":"BF03189993_CR26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/taap.1996.8093","volume":"143","author":"S.M. Furst","year":"1997","unstructured":"Furst S.M., Luedke D., Gaw H.H., Reich R., Gandolfi A.J. (1997): Demonstration of a cellular immune response in halothane-exposed guinea pigs. Toxicol. Appl. Pharmacol., 143, 245\u2013255.","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"BF03189993_CR27","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1073\/pnas.88.4.1407","volume":"88","author":"J.W. Harris","year":"1991","unstructured":"Harris J.W., Pohl L.R., Martin J.L., Anders, M. W. (1991): Tissue acylation by the chlorofluorocarbon substitute 2,2-dichloro-1,1,1-trifluoroethane. Proc. Natl. Acad. Sci. U.S.A., 88, 1407\u20131410.","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"BF03189993_CR28","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1021\/tx00029a020","volume":"5","author":"J.W. Harris","year":"1992","unstructured":"Harris J.W., Jones J.P., Martin J.L., Larosa A.C., Olson M.J., Pohl L.R., Anders M.W. (1992): Pentahaloethane-based chlorofluorocarbon substitutes and halothane: correlation of invivo hepatic protein trifluoroacetylation and urinary trifluoroacetic acid excretion with calculated enthalpies of activation. Chem. Res. Toxicol., 5, 720\u2013725.","journal-title":"Chem. Res. Toxicol."},{"issue":"9077","key":"BF03189993_CR29","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(97)03094-8","volume":"350","author":"P. Hoet","year":"1997","unstructured":"Hoet P., Graf M.L.M., Bourdi M., Pohl L.R., Duray P.H., Chen W.Q., Peter R.M., Nelson S.D., Verlinden N., Lison D. (1997): Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone-sparing substitutes of chlorofluorocarbons. Lancet, 350: 9077, 556\u2013559.","journal-title":"Lancet"},{"key":"BF03189993_CR30","first-page":"1881","volume":"9","author":"R. Poupon","year":"1980","unstructured":"Poupon R., Homberg J.C., Abuaf N., Petit J., Bodin F., Darnis F. (1980): Atteintes h\u00e9patiques dues \u00e0 l\u2019acide ti\u00e9nilique. Six observations avec pr\u00e9sence d\u2019anticorps antireticulum endoplasmique. Nouv. Presse Med., 9, 1881\u20131884.","journal-title":"Nouv. Presse Med."},{"key":"BF03189993_CR31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/hep.1840040223","volume":"4","author":"H.J. Zimmerman","year":"1984","unstructured":"Zimmerman H.J., Lewis J.H., Ishak K.G., Maddrey W. (1984): Ticrynafen- associated hepatic injury: analysis of 340 cases. Hepatology, 4, 315\u2013323.","journal-title":"Hepatology"},{"key":"BF03189993_CR32","first-page":"2475","volume":"10","author":"M. Colliard","year":"1981","unstructured":"Colliard M., Homberg J.C., Tcherdakoff Ph. (1981): Hypertendus trait\u00e9s \u00e0 l\u2019acide ti\u00e9nilique. Etude r\u00e9trospective de 298 observations. Nouv. Presse Med., 10, 2475\u20132478.","journal-title":"Nouv. Presse Med."},{"key":"BF03189993_CR33","first-page":"561","volume":"55","author":"J.C. Homberg","year":"1984","unstructured":"Homberg J.C., Andr C., Abuaf N. (1984): A new antiliver-kidney-microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis. Clin. Exp. Immunol., 55, 561\u2013570","journal-title":"Clin. Exp. Immunol."},{"key":"BF03189993_CR34","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/hep.1840050504","volume":"5","author":"J.C. Homberg","year":"1985","unstructured":"Homberg J.C., Abuaf N., Helmy-Khalil S., Biour M., Poupon R., Islam S., Darnis F., Levy V.G., Opolon P., Beaugrand M., Toulet J., Danan G., Benhamou J.P. (1985): Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. Hepatology, 5, 722\u2013727.","journal-title":"Hepatology"},{"key":"BF03189993_CR35","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/0006-2952(84)90409-X","volume":"33","author":"D. Mansuy","year":"1984","unstructured":"Mansuy D., Dansette P., Foures C., Jaouen M., Moinet G., Bayer N. (1984): Metabolic hydroxylation of the thiophene ring: isolation of 5-hydroxytienilic acid as the major urinary metabolite in rat and man. Biochem. Pharmacol., 33,1429\u20131435.","journal-title":"Biochem. Pharmacol."},{"key":"BF03189993_CR36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0006-2952(91)90627-H","volume":"41","author":"P.M. Dansette","year":"1991","unstructured":"Dansette P.M., Amar C., Valadon P., Pons C., Beaune P.H., Mansuy D. (1991): Hydroxylation and formation of electrophilic metabolites of tienilic acid and its isomer by human liver microsomes: catalysis by a P450IIC different from that responsible for mephenytoin hydroxylation. Biochem. Pharmacol., 41,553\u2013560.","journal-title":"Biochem. Pharmacol."},{"key":"BF03189993_CR37","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1021\/tx00039a023","volume":"7","author":"S. Lecoeur","year":"1994","unstructured":"Lecoeur S., Bonierbale E., Challine D., Gautier J.C., Valadon P., Dansette P.M., Catinot R., Ballet F., Mansuy D., Beaune P.H. (1994): Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity. Chem. Res. Toxicol., 7, 434\u2013442.","journal-title":"Chem. Res. Toxicol."},{"key":"BF03189993_CR38","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1021\/bi00167a022","volume":"33","author":"M.P. Lopez-Garzia","year":"1994","unstructured":"Lopez-Garzia M.P., Dansette P.M., Mansuy D. (1994): Thiophene derivatives as new mechanism-based inhibitors of cytochrome-P-450: inactivation of yeast- expressed human liver cytochrome P-450-2C9 by tienilic acid. Biochemistry, 33, 166\u2013175.","journal-title":"Biochemistry"},{"key":"BF03189993_CR39","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1073\/pnas.84.2.551","volume":"84","author":"P.H. Beaune","year":"1987","unstructured":"Beaune P.H., Dansette P.M., Mansuy D., Kiffel L., Finck M., Amar C., Leroux J.P., Homberg J.C. (1987): Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P450 that hydroxylates the drug. Proc. Natl. Acad. Sci. U.S.A., 84, 551\u2013555.","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"BF03189993_CR40","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0022-3565(25)20545-6","volume":"259","author":"C. Pons","year":"1991","unstructured":"Pons C., Dansette P.M., Amar C., Jaouen M., Wolf C.R., Gregeois J., Homberg J.C., Mansuy D. (1991): Detection of human hepatitis anti-liver kidney microsomes (LKM2) autoantibodies on rat liver sections is predominantly due to reactivity with rat liver P-450-IIC11. J. Pharmacol. Exper. Ther., 259, 1328\u20131334.","journal-title":"J. Pharmacol. Exper. Ther."},{"key":"BF03189993_CR41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0016-5085(93)90853-5","volume":"104","author":"J. Loeper","year":"1993","unstructured":"Loeper J., Descatoire V., Maurice M., Beaune P., Belghiti J., Houssin D., Ballet F., Feldmann G., Guengerich F.P., Pessayre D. (1993): Cytochromes-P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies. Gastroenterology, 104, 203\u2013216.","journal-title":"Gastroenterology"},{"key":"BF03189993_CR42","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/hep.1840110521","volume":"11","author":"J. Loeper","year":"1990","unstructured":"Loeper J., Descatoire V., Maurice M., Beaune P., Feldmann G., Larrey D., Pessayre D. (1990): Presence of functional cytochrome-P-450 on isolated rat hepatocyte plasma membrane. Hepatology, 11, 850\u2013858.","journal-title":"Hepatology"},{"key":"BF03189993_CR43","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1021\/ja00020a089","volume":"113","author":"D. Mansuy","year":"1991","unstructured":"Mansuy D., Valadon P., Erdelmeier I., Lepez-Garcia M.P., Amar C., Girault J.P., Dansette P.M. (1991): Thiophene-S-oxides as new reactive metabolites: formation by cytochrome P450- dependent oxidation and reaction with nucleophils. J. Am. Chem. Soc., 113, 7825\u20137826","journal-title":"J. Am. Chem. Soc."},{"key":"BF03189993_CR44","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1021\/tx9601622","volume":"9","author":"P. Valadon","year":"1996","unstructured":"Valadon P., Dansette P.M., Girault J.P., Amar C., Mansuy D. (1996): Thiophene sulfoxides as reactive metabolites: formation upon microsomal oxidation of a 3- aroylthiophene and fate in the presence of nucleophiles in vitro and in vivo. Chem. Res. Toxicol., 9, 1403\u20131413.","journal-title":"Chem. Res. Toxicol."},{"key":"BF03189993_CR45","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0006-291X(05)81594-3","volume":"186","author":"P.M. Dansette","year":"1992","unstructured":"Dansette P.M., Thang D.C., El Amri H., Mansuy D. (1992): Evidence for thiophene- S-oxide as a primary reactive metabolite of thiophene in vivo: formation of a dihydrothiophene sulfoxide mercapturic acid. Biochem. Biophys. Res. Commun., 186, 1624\u20131630.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BF03189993_CR46","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/ja962466g","volume":"119","author":"A. Treiber","year":"1997","unstructured":"Treiber A., Dansette P.M., El Amri H., Girault J.P., Ginderow D., Mornon J.P., Mansuy D. (1997): Chemical and biological oxidation of thiophene: preparation and complete characterization of thiophene S-oxide dimers and evidence for thiophene-S-oxide as an intermediate in thiophene metabolism in vivo and in vitro. J. Am. Chem. Soc., 119, 1565\u20131571.","journal-title":"J. Am. Chem. Soc."},{"key":"BF03189993_CR47","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/0016-5085(95)90210-4","volume":"108","author":"M.A. Robin","year":"1995","unstructured":"Robin M.A., Maratrat M., Loeper J., Durand-Schneider A.M., Tinel M., Ballet F., Beaune P., Feldmann G., Pessayre, D. (1995): Cytochrome P4502B follows a vesicular route to the plasma membrane in cultured rat hepatocytes. Gastroenterology, 108, 1110\u20131123.","journal-title":"Gastroenterology"},{"key":"BF03189993_CR48","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1172\/JCI118936","volume":"98","author":"M.A. Robin","year":"1996","unstructured":"Robin M.A., Maratrat M., Leroy M., Lebreton F.P., Bonierbale E., Dansette P.M., Ballet F., Mansuy D., Pessayre D. (1996): Antigenic targets in tienilic acid hepatitis: both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera. J. Clin. Invest., 98, 1471\u20131480.","journal-title":"J. Clin. Invest."},{"key":"BF03189993_CR49","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0026-895X(25)09234-X","volume":"50","author":"S. Lecoeur","year":"1996","unstructured":"Lecoeur S., Andr\u00e9 C., & Beaune P.H. (1996): Tienilic acid-induced autoimmune hepatitis: Anti- liver and \u2014 kidney microsomal type 2 autoantibodies recognize a three-site conformational epitope on cytochrome P4502C9. Mol. Pharmacol., 50, 326\u2013333.","journal-title":"Mol. Pharmacol."},{"key":"BF03189993_CR50","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/(SICI)1097-0134(199707)28:3<388::AID-PROT9>3.0.CO;2-8","volume":"28","author":"P. Jean","year":"1997","unstructured":"Jean P., Pothier J., Dansette P.M., Mansuy D., Viari A. (1997): Automated multiple analysis of protein structures: application to homology modeling of cytochromes P450. Protein Struct. Funct. Genet., 28, 388\u2013404.","journal-title":"Protein Struct. Funct. Genet."},{"key":"BF03189993_CR51","first-page":"127","volume":"136","author":"G. Roschlau","year":"1990","unstructured":"Roschlau G., Baumgarten R., Fengler J.D. (1990): Die Dihydralazin Hepatitis. Zentralbl. Allg. Pathol. Pathol. Anat., 136, 127\u2013134.","journal-title":"Zentralbl. Allg. Pathol. Pathol. Anat."},{"key":"BF03189993_CR52","first-page":"167","volume":"134","author":"G. Machnik","year":"1988","unstructured":"Machnik G., Bergert A., Justus J., Kunze P., M\u00a5ller R., Reinhardt M., Schulz H., Stein G., Thiele R. (1988): Arzneimittelhepatitis nach Dihydralazin mit t\u00f6dlichem Verlauf. Zentralbl. Allg. Pathol. Pathol. Anat., 134, 167\u2013177.","journal-title":"Zentralbl. Allg. Pathol. Pathol. Anat."},{"key":"BF03189993_CR53","first-page":"33","volume":"43","author":"T. Schneider","year":"1988","unstructured":"Schneider T., Siegmund W., Zschiesche M., Kallwellis R., Scherber A. (1988): Zum qualitativen Nachweis von Metaboliten des Dihydralazins beim Menschen. Pharmazie, 43, 33\u201336.","journal-title":"Pharmazie"},{"key":"BF03189993_CR54","first-page":"439","volume":"41","author":"L.W. Schr-der","year":"1986","unstructured":"Schr-der L.W., Siegmund W., Schneider T., Lohberg T., Grisk A. (1986): Zur Blutdruckwirksamkeit ausgew\u00a2lhter Dihydralazinmetabolite. Pharmazie, 41, 439.","journal-title":"Pharmazie"},{"key":"BF03189993_CR55","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0026-895X(25)10602-0","volume":"45","author":"M. Bourdi","year":"1994","unstructured":"Bourdi M., Tinel M., Beaune P., Pessayre D. (1994): Interactions of dihydralazine with cytochromes P4501A: a possible explanation for the appearance of anticytochrome P4501A2 autoantibodies. Mol. Pharmacol., 45, 1287\u20131295.","journal-title":"Mol. Pharmacol."},{"key":"BF03189993_CR56","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0026-895X(25)08911-4","volume":"42","author":"M. Bourdi","year":"1992","unstructured":"Bourdi M., Gautier J.C., Mircheva J., Larrey D., Guillouzo A., Andr\u00e9 C., Belloc C., Beaune P.H. (1992): Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug. Mol. Pharmacol., 42, 280\u2013285.","journal-title":"Mol. Pharmacol."},{"key":"BF03189993_CR57","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1172\/JCI114660","volume":"85","author":"M. Bourdi","year":"1990","unstructured":"Bourdi M., Larrey D., Nataf J., Bernuau J., Pessayre D., Iwasaki M., Guengerich F.P., Beaune P.H. (1990): Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P450 IA2: a specific marker of dihydralazine- induced hepatitis. J. Clin. Invest., 85, 1967\u20131973.","journal-title":"J. Clin. Invest."},{"key":"BF03189993_CR58","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00008571-199706000-00002","volume":"7","author":"C. Belloc","year":"1997","unstructured":"Belloc C., Gauffre A., Andr\u00e9 C., Beaune P.H. (1997): Epitope mapping of human CYP1A2 in dihydralazine-induced autoimmune hepatitis. Pharmacogenetics, 7, 181\u2013186.","journal-title":"Pharmacogenetics"},{"key":"BF03189993_CR59","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/bbrc.1993.1180","volume":"191","author":"R.J. Riley","year":"1993","unstructured":"Riley R.J., Smith G., Wolf C.R., Cook V.A., Leeder J.S. (1993): Human anti-endoplasmic reticulum autoantibodies produced in aromatic anticonvulsant hypersensitivity reactions recognise rodent CYP 3A proteins and similarly regulated human P450 enzymes. Biochem. biophys. Res. Commun., 191, 32\u201340 (corr.: 194, p. 585).","journal-title":"Biochem. biophys. Res. Commun."},{"key":"BF03189993_CR60","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0022-3565(25)10348-0","volume":"263","author":"J.S. Leeder","year":"1992","unstructured":"Leeder J.S., Riley R.J., Cook V.A., Spielberg P. (1992): Human anti-cytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions. J. Pharmacol. Exp. Ther., 263, 360\u2013367.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF03189993_CR61","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1172\/JCI113798","volume":"82","author":"H. Shear","year":"1988","unstructured":"Shear H., Spielberg S.P. (1988): Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J. Clin. Invest., 82, 1826\u20131832.","journal-title":"J. Clin. Invest."},{"key":"BF03189993_CR62","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJM198109243051302","volume":"305","author":"S.P. Spielberg","year":"1981","unstructured":"Spielberg S.P., Gordon G.B., Blake G.B., Goldstein D.A., Herlong H.F. (1981): Predisposition to phenytoin hepatotoxicity assessed in vitro. N. Engl. J. Med., 305, 722\u2013727.","journal-title":"N. Engl. J. Med."},{"key":"BF03189993_CR63","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0026-895X(25)08704-8","volume":"49","author":"J. S. Leeder","year":"1996","unstructured":"Leeder J. S., Gaedigk A., Lu X.L., Cook V. A. (1996): Epitope mapping studies with human anti-cytochrome P450 3A antibodies. Mol. Pharmacol., 49, 234\u2013243. (corr.: p. 760).","journal-title":"Mol. Pharmacol."},{"key":"BF03189993_CR64","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/bbrc.1996.0021","volume":"218","author":"C. Pons","year":"1996","unstructured":"Pons C., Dansette P.M., Gregeois J., Homberg J.C., Billett E.E., Mansuy D. (1996): Human anti-mitochondria autoantibodies appearing in iproniazid-induced immunoallergic hepatitis recognize human liver monoamine oxidase B. Biochem. Biophys. Res. Commun., 218, 118\u2013124.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BF03189993_CR65","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1056\/NEJM198007103030202","volume":"303","author":"D. Vergani","year":"1980","unstructured":"Vergani D., Mieli-Vergani G., Alberti A., Neuberger J., Eddleston A.L.W.F., Williams R. (1980): Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N. Engl. J. Med., 303, 66\u201371.","journal-title":"N. Engl. J. Med."},{"key":"BF03189993_CR66","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/gut.30.4.515","volume":"30","author":"J.M. Neuberger","year":"1989","unstructured":"Neuberger J.M., Williams R. (1989): Immune mechanisms in tienilic acid-associated hepatotoxicity. Gut, 30, 515\u2013519.","journal-title":"Gut"},{"key":"BF03189993_CR67","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0003-9861(90)90541-6","volume":"280","author":"M.P. Manns","year":"1990","unstructured":"Manns M.P., Griffin K.J., Quattrochi L.C., Sacher M., Thaler H., Tukey R.H., Johnson E.F. (1990): Identification of cytochrome-P450Ia2 as a human autoantigen. Archives Biochem. Biophys. 280, 229\u2013232.","journal-title":"Archives Biochem. Biophys."},{"key":"BF03189993_CR68","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM197008062830602","volume":"283","author":"F. Paronetto","year":"1970","unstructured":"Paronetto F., Popper H. (1970): Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane. N. Engl. J. Med., 283, 277\u2013280.","journal-title":"N. Engl. J. Med."},{"key":"BF03189993_CR69","first-page":"509","volume":"130","author":"K.D. Kunze","year":"1985","unstructured":"Kunze K.D., Porst H., Tsch\u00f6pel L. (1985): Morphologie und Pathogenese von Lebersch\u00e4den durch Dihydralazin, Propanolol und Ketophenylbutazon. Zentralbl. Allg. Pathol. Pathol. Anat., 130, 509\u2013518.","journal-title":"Zentralbl. Allg. Pathol. Pathol. Anat."},{"key":"BF03189993_CR70","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1021\/tx9700836","volume":"10","author":"A.J. Munns","year":"1997","unstructured":"Munns A.J., De Voss J.J., Hooper W.D., Dickinson R.G., Gillam E.M.J. (1997): Bioactivation of phenytoin by human cytochrome P450: characterisation of the mechanism and targets of covalent adduct formation. Chem. Res. Toxicol., 10, 1049\u20131058.","journal-title":"Chem. Res. Toxicol."}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03189993.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03189993\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03189993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T19:33:12Z","timestamp":1740339192000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03189993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,12]]}},"alternative-id":["BF03189993"],"URL":"https:\/\/doi.org\/10.1007\/bf03189993","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12]]}}}